Clinical Trial Update: VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption [Phase 1]

View source ↗

Summary

A Phase 1 trial of the HIV-neutralizing antibody VRC01 (VRC-HIVMAB060-00-AB) in people with chronic HIV infection undergoing analytical treatment interruption h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VRC-HIVMAB060-00-AB (VRC01) (VRC01)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 1 | Status: COMPLETED | Results posted: 2017-10-31